CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Increase in Short Interest
by Amy Steele · The Cerbat GemCBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 202,600 shares, a growth of 21.6% from the September 30th total of 166,600 shares. Based on an average trading volume of 67,047,700 shares, the short-interest ratio is presently 0.0 days.
CBD Life Sciences Stock Performance
CBDL traded up $0.00 during midday trading on Monday, reaching $0.00. 80,377,766 shares of the company’s stock were exchanged, compared to its average volume of 7,484,593. CBD Life Sciences has a one year low of $0.00 and a one year high of $0.03.
About CBD Life Sciences
CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.
See Also
- Five stocks we like better than CBD Life Sciences
- What is the NASDAQ Stock Exchange?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Oil Stocks to Watch Before Earnings Come Out
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?